María J. Perugorria

机构：University of the Basque Country, Instituto de Salud Carlos III, Biogipuzkoa Health Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Onkologikoa · ORCID：0000-0002-7636-0972

发表论文 169 篇 · 总被引 9485 次 · h-index 43

代表论文

• Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) (2024 · Atherosclerosis · 被引 80)
• Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 71)
• Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma (2023 · Gastroenterology · 被引 35)
• Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma (2023 · Cancers · 被引 16)
• m 6 A Methylated Long Noncoding RNA LOC339803 Regulates Intestinal Inflammatory Response (2024 · Advanced Science · 被引 15)
• New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas (2025 · Journal of Hepatology · 被引 14)